MARKET

IDXX

IDXX

IDEXX Labs
NASDAQ

Real-time Quotes | Nasdaq Last Sale

682.58
+11.11
+1.65%
Pre Market: 680.00 -2.58 -0.38% 08:08 09/24 EDT
OPEN
674.99
PREV CLOSE
671.47
HIGH
689.95
LOW
670.66
VOLUME
9
TURNOVER
--
52 WEEK HIGH
706.95
52 WEEK LOW
361.17
MARKET CAP
58.07B
P/E (TTM)
81.41
1D
5D
1M
3M
1Y
5Y
Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day
Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day
Zacks · 23h ago
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
Zacks.com · 1d ago
Bet on These 3 MedTech Growth Stocks for 2021 & Beyond
Stocks like West Pharmaceutical Services (WST), IDEXX Laboratories (IDXX) and Align Technology (ALGN) make great picks for the long term.
Zacks · 1d ago
Here's Why You Should Retain Globus Medical (GMED) for Now
Zacks.com · 1d ago
Ocular Therapeutix(TM) Appoints Merilee Raines to Its Board of Directors
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the appointment of Merilee Raines to the Comp...
Business Wire · 2d ago
Here's Why You Should Retain Walgreens (WBA) Stock for Now
Investors are optimistic about Walgreens (WBA), given the strong performance in the International segment and notable product launches.
Zacks · 2d ago
Here's Why You Should Retain Inogen (INGN) Stock For Now
Zacks.com · 2d ago
PacBio (PACB) Closes Omniome Buyout, Forays Into San Diego
Zacks.com · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IDXX. Analyze the recent business situations of IDEXX Labs through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IDXX stock price target is 717.50 with a high estimate of 770.00 and a low estimate of 610.00.
EPS
Institutional Holdings
Institutions: 1.27K
Institutional Holdings: 84.78M
% Owned: 99.65%
Shares Outstanding: 85.08M
TypeInstitutionsShares
Increased
318
2.76M
New
101
459.98K
Decreased
376
2.51M
Sold Out
71
201.52K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.88%
Healthcare Equipment & Supplies
+0.77%
Key Executives
Non-Executive Chairman/Independent Director
Lawrence Kingsley
President/Chief Executive Officer/Director
Jonathan Mazelsky
Chief Financial Officer/Executive Vice President/Treasurer
Brian McKeon
Chief Human Resource Officer/Senior Vice President
Giovani Twigge
Executive Vice President/General Manager
Tina Hunt
Executive Vice President/General Manager
Michael Lane
Executive Vice President
James Polewaczyk
Senior Vice President/Chief Marketing Officer
Kathy Turner
Senior Vice President/General Counsel/Secretary
Sharon Underberg
Director
Jonathan Ayers
Independent Director
Bruce Claflin
Independent Director
Asha Collins
Independent Director
Stuart Essig
Independent Director
Daniel Junius
Independent Director
Sam Samad
Independent Director
M. Anne Szostak
Independent Director
Sophie Vandebroek
No Data
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Webull offers kinds of IDEXX Laboratories, Inc. stock information, including NASDAQ:IDXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IDXX stock methods without spending real money on the virtual paper trading platform.